OSR HOLDINGS INC (NASDAQ: OSRH)

OSR HOLDINGS INC

NASDAQ: OSRH (OSR Holdings, Inc.)

Kemas kini terakhir: 4 hari lalu, 8:09AM

0.700

-0.01 (-1.62%)

Tambah ke senarai pantauan

Penutupan Terdahulu	0.712
Buka	0.690
Jumlah Dagangan	620,319
Purata Dagangan (3B)	4,923,322
Modal Pasaran	17,973,518

Harga / Jualan (P/S)	108.29
Harga / Buku (P/B)	0.230

Julat 52 Minggu

0.453 (-35%) — 12.54 (1691%)

Arah Aliran Pasaran

		Jangka Pendek	Jangka Sederhana
Industri	Biotechnology (US)	Menaik	Bercampur
	Biotechnology (Global)	Menaik	Bercampur
Stok	OSR Holdings, Inc.	-	-

AISkor Stockmoo

0.5

Konsensus Penganalisis	2.0
Aktiviti Orang Dalam	NA
Volatiliti Harga	-2.0
Purata Bergerak Teknikal	0.0
Osilator Teknikal	2.0
Purata	0.50

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
OSRH	18 M	-	-	0.230
LEGN	5 B	-	-	5.06
MAZE	2 B	-	-	4.82
ELVN	1 B	-	-	2.56
JBIO	570 M	-	-	-
NBP	460 M	-	-	2.25

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Sektor	Healthcare
Industri	Biotechnology
% Dimiliki oleh Orang Dalam	62.40%
% Dimiliki oleh Institusi	0.35%

Tiada data dalam julat masa ini.

Tarikh	Jenis	Butiran
04 Dec 2025	Pengumuman	Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement
02 Dec 2025	Pengumuman	Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
01 Dec 2025	Pengumuman	OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
21 Nov 2025	Pengumuman	Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones
14 Nov 2025	Pengumuman	OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
06 Nov 2025	Pengumuman	OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study
20 Oct 2025	Pengumuman	Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target
14 Oct 2025	Pengumuman	OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care
09 Sep 2025	Pengumuman	OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

Log masuk untuk menambahkan ke senarai pantauan

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Log masuk untuk menambahkan ke senarai pantauan

Keuntungan Nyata	-
Keuntungan Tidak Nyata	-
Dividen Diterima 2025	-
Jumlah Untung	-
Pulangan Purata	-
Kuantiti (Beli)	-
Purata Harga (Beli)	-
Kuantiti (Jual)	-
Purata Harga (Jual)	-

Log masuk untuk menambahkan ke senarai pantauan

Tiada saham yang memenuhi kriteria anda

Margin Operasi (TTM)	-383.28%
EPS Cair (TTM)	-0.540
Pertumbuhan Hasil Suku Tahunan (YOY)	-16.40%
Pertumbuhan Pendapatan Suku Tahunan (YOY)	-30.50%

Jumlah Hutang/Ekuiti (D/E MRQ)	3.61%
Nisbah Semasa (MRQ)	0.250
Aliran Tunai Operasi (OCF TTM)	-1.75 M

Pulangan Atas Aset (ROA TTM)	-11.32%
Pulangan Atas Ekuiti (ROE TTM)	-18.52%

Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)